Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Oxford’s early detection research is highlighted at this year’s virtual gathering of the Oxford cancer community.

Similar stories

FDA clearance for Oxford spin-out’s early lung cancer diagnosis software

Lung cancer

Optellum, an Oxford-based lung health company aiming to redefine early diagnosis and treatment of lung disease, has received FDA clearance for its AI-powered clinical decision support software.

DeLIVER clinical research study underway

Liver cancer TAPS

The DELPHI project, one of three clinical studies within the DeLIVER programme for early detection of liver cancer, has started recruiting patients.